Characterization of the enhanced infectivity and antibody evasion of Omicron BA.2.75

Recently emerged SARS-CoV-2 Omicron subvariant, BA.2.75, displayed a growth advantage over circulating BA.2.38, BA.2.76, and BA.5 in India. However, the underlying mechanisms for enhanced infectivity, especially compared with BA.5, remain unclear. Here, we show that BA.2.75 exhibits substantially hi...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Yunlong, Song, Weiliang, Wang, Lei, Liu, Pan, Yue, Can, Jian, Fanchong, Yu, Yuanling, Yisimayi, Ayijiang, Wang, Peng, Wang, Yao, Zhu, Qianhui, Deng, Jie, Fu, Wangjun, Yu, Lingling, Zhang, Na, Wang, Jing, Xiao, Tianhe, An, Ran, Liu, Lu, Yang, Sijie, Niu, Xiao, Gu, Qingqing, Shao, Fei, Hao, Xiaohua, Meng, Bo, Gupta, Ravindra Kumar, Jin, Ronghua, Wang, Youchun, Xie, Xiaoliang Sunney, Wang, Xiangxi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531665/
https://www.ncbi.nlm.nih.gov/pubmed/36270286
http://dx.doi.org/10.1016/j.chom.2022.09.018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531665/
https://www.ncbi.nlm.nih.gov/pubmed/36270286
http://dx.doi.org/10.1016/j.chom.2022.09.018

Ejemplares similares